GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » Price-to-Owner-Earnings

Biohit Oyj (OHEL:BIOBV) Price-to-Owner-Earnings : 24.75 (As of May. 14, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj Price-to-Owner-Earnings?

As of today (2024-05-14), Biohit Oyj's share price is €1.98. Biohit Oyj's Owner Earnings per Share (TTM) ended in Dec. 2023 was €0.08. It's Price-to-Owner-Earnings for today is 24.75.


The historical rank and industry rank for Biohit Oyj's Price-to-Owner-Earnings or its related term are showing as below:

OHEL:BIOBV' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.85   Med: 17.39   Max: 208
Current: 26.67

During the past 13 years, the highest Price-to-Owner-Earnings of Biohit Oyj was 208.00. The lowest was 5.85. And the median was 17.39.


OHEL:BIOBV's Price-to-Owner-Earnings is ranked better than
58.33% of 168 companies
in the Biotechnology industry
Industry Median: 35.165 vs OHEL:BIOBV: 26.67

As of today (2024-05-14), Biohit Oyj's share price is €1.98. Biohit Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.12. Therefore, Biohit Oyj's PE Ratio for today is 16.50.

As of today (2024-05-14), Biohit Oyj's share price is €1.98. Biohit Oyj's EPS without NRI for the trailing twelve months (TTM) ended in was €0.12. Therefore, Biohit Oyj's PE Ratio without NRI for today is 16.50.

During the past 13 years, Biohit Oyj's highest PE Ratio without NRI was 54.74. The lowest was 15.99. And the median was 48.16.


Biohit Oyj Price-to-Owner-Earnings Historical Data

The historical data trend for Biohit Oyj's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj Price-to-Owner-Earnings Chart

Biohit Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 168.00 - - 14.14 25.13

Biohit Oyj Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 14.14 - 25.13

Competitive Comparison of Biohit Oyj's Price-to-Owner-Earnings

For the Biotechnology subindustry, Biohit Oyj's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biohit Oyj's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biohit Oyj's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's Price-to-Owner-Earnings falls into.



Biohit Oyj Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Biohit Oyj's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1.98/0.08
=24.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohit Oyj  (OHEL:BIOBV) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Biohit Oyj Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Biohit Oyj (OHEL:BIOBV) Business Description

Traded in Other Exchanges
N/A
Address
Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines